OncoResponse is the older company (2020 vs 2016); Valink Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Valink Therapeutics | OncoResponse |
|---|---|---|
| Founded | ||
| Founded | 2020 | 2016 older |
| Headquarters | ||
| Headquarters | Cambridge, United States | Houston, United States |
| Employees | ||
| Employees | 31 larger | 10 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Seed | Unknown |
| Total Funding | ||
| Total Funding | Not tracked yet | $117.10M |
| Funding Rounds | ||
| Funding Rounds | 2 | 6 |
| Services | ||
| Services | Drug Discovery and Development, Therapeutic Design and Optimization, Biologics Research, Pipeline Development | Development of novel cancer immunotherapies, Discovery of human antibodies, Partnering with collaborators in immuno-oncology, Preclinical studies |
| Target Customers | ||
| Target Customers | Pharmaceutical Companies, Biotech Researchers, Medical Professionals, Cancer Treatment Facilities, Healthcare Institutions | Biopharmaceutical companies, Oncology researchers, Cancer patients, Clinical study collaborators |
| Taxonomy | ||
| Taxonomy | Antibody-Drug Conjugates, BsADCs, Platform Therapeutics, Oncology, Solid Tumors, Multivalent Antibodies, Bispecific Antibodies, Novel Target Combinations, Protein Technology Platform, Biologics Discovery, Venture Capital-backed, Y Combinator-incubated, University Spin-out | Immuno-oncology, Biotech, Cancer Immunotherapy, Antibody Platform, B-cell Discovery, Tumor Microenvironment, Monoclonal Antibodies, Immune Activation, TME Immunosuppression, Elite Cancer Responders, Novel Therapeutics, Myeloid Biology, Clinical Trials, Human Antibodies |
| Website | ||
| Website | valinktx.com | oncoresponse.com |
About Valink Therapeutics
Valink Therapeutics, with its slogan "Making better ADCs," is pioneering the development of novel multivalent bispecific antibody-drug conjugates (bsADCs) designed to revolutionize the treatment of solid tumors and other critical health conditions. The company's innovative approach focuses on non-ob...
About OncoResponse
OncoResponse, founded in 2016, is an innovative player in the immuno-oncology biotech sector. This biopharma company is particularly notable for its strategic collaboration with the MD Anderson Cancer Center, which amplifies its capabilities in treating cancer. Utilizing a proprietary B-cell discov...
We will tell you when either one moves
BounceWatch watches Valink Therapeutics and OncoResponse for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Valink Therapeutics and OncoResponse — by email.
Frequently Asked Questions
Compare Valink Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Valink Therapeutics on 22 Mar 2026, and OncoResponse on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.